Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Belot

Showing results (81-90 of 250) with videos related to

Pageof 25
Sort By:
Journal of Clinical Medicine|April 13, 2023
Rescue of Pap-Mas in Systemic JIA Using Janus Kinase Inhibitors, Case Report and Systematic ReviewFranck Zekre, Anita Duncan, Audrey Laurent, et al.
Clinical and Experimental Rheumatology|October 24, 2025
Clinical predictors of remission in systemic juvenile idiopathic arthritis/Still's disease: insight from real-life data and the potential relevance of the 'window of opportunity'Sarah Abu-Rumeileh, Maria Vincenza Mastrolia, Audrey Laurent, et al.
Clinical Case Reports|October 29, 2015
Early-onset hypoparathyroidism and chronic keratitis revealing APECEDEllia Mezgueldi, Aurélia Bertholet-Thomas, Solange Milazzo, et al.
Frontiers in Oncology|February 7, 2022
Neutralizing Anti-IL-17A Antibody Demonstrates Preclinical Activity Enhanced by Vinblastine in Langerhans Cell HistiocytosisSelma Olsson Åkefeldt, Mohamad Bachar Ismail, Alexandre Belot, et al.
Joint Bone Spine|February 27, 2025
Sustained remission after bispecific antibody anti-IL-1β/anti-IL-18 therapy in a severe childhood Still's disease with recurrent macrophage activation syndromeJade Cognard, Jonathan Sormani, Malo Freppel, et al.
Annals of the Rheumatic Diseases|December 25, 2017
ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitisPierre Quartier, Amandine Baptiste, Véronique Despert, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 27, 2018
Deletion of Inflammasome Components Is Not Sufficient To Prevent Fatal Inflammation in Models of Familial Hemophagocytic LymphohistiocytosisSébastien Fauteux-Daniel, Sébastien Viel, Laurie Besson, et al.
Frontiers in Pharmacology|January 28, 2021
Long-Term Follow-Up and Optimization of Interleukin-1 Inhibitors in the Management of Monogenic Autoinflammatory Diseases: Real-Life Data from the JIR CohortVéronique Hentgen, Isabelle Koné-Paut, Alexandre Belot, et al.
Rheumatology (Oxford, England)|August 3, 2022
JAK inhibitors in difficult-to-treat adult-onset Still's disease and systemic-onset juvenile idiopathic arthritisLouise Gillard, Jacques Pouchot, Fleur Cohen-Aubart, et al.
Journal of Clinical Immunology|April 15, 2024
Mendelian Causes of Autoimmunity: the Lupus PhenotypeMaud Tusseau, Samira Khaldi-Plassart, Jade Cognard, et al.
Pageof 25

Showing results (81-90 of 250) with videos related to

Sort By:
Pageof 25
Journal of Clinical Medicine|April 13, 2023
Rescue of Pap-Mas in Systemic JIA Using Janus Kinase Inhibitors, Case Report and Systematic ReviewFranck Zekre, Anita Duncan, Audrey Laurent, et al.
Clinical and Experimental Rheumatology|October 24, 2025
Clinical predictors of remission in systemic juvenile idiopathic arthritis/Still's disease: insight from real-life data and the potential relevance of the 'window of opportunity'Sarah Abu-Rumeileh, Maria Vincenza Mastrolia, Audrey Laurent, et al.
Clinical Case Reports|October 29, 2015
Early-onset hypoparathyroidism and chronic keratitis revealing APECEDEllia Mezgueldi, Aurélia Bertholet-Thomas, Solange Milazzo, et al.
Frontiers in Oncology|February 7, 2022
Neutralizing Anti-IL-17A Antibody Demonstrates Preclinical Activity Enhanced by Vinblastine in Langerhans Cell HistiocytosisSelma Olsson Åkefeldt, Mohamad Bachar Ismail, Alexandre Belot, et al.
Joint Bone Spine|February 27, 2025
Sustained remission after bispecific antibody anti-IL-1β/anti-IL-18 therapy in a severe childhood Still's disease with recurrent macrophage activation syndromeJade Cognard, Jonathan Sormani, Malo Freppel, et al.
Annals of the Rheumatic Diseases|December 25, 2017
ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitisPierre Quartier, Amandine Baptiste, Véronique Despert, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 27, 2018
Deletion of Inflammasome Components Is Not Sufficient To Prevent Fatal Inflammation in Models of Familial Hemophagocytic LymphohistiocytosisSébastien Fauteux-Daniel, Sébastien Viel, Laurie Besson, et al.
Frontiers in Pharmacology|January 28, 2021
Long-Term Follow-Up and Optimization of Interleukin-1 Inhibitors in the Management of Monogenic Autoinflammatory Diseases: Real-Life Data from the JIR CohortVéronique Hentgen, Isabelle Koné-Paut, Alexandre Belot, et al.
Rheumatology (Oxford, England)|August 3, 2022
JAK inhibitors in difficult-to-treat adult-onset Still's disease and systemic-onset juvenile idiopathic arthritisLouise Gillard, Jacques Pouchot, Fleur Cohen-Aubart, et al.
Journal of Clinical Immunology|April 15, 2024
Mendelian Causes of Autoimmunity: the Lupus PhenotypeMaud Tusseau, Samira Khaldi-Plassart, Jade Cognard, et al.
Pageof 25